The current business environment depends on a complex system of contractual agreements and business relationships, which leads to conflicts that ...

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to study results.Patients determined by a biology-guided AI model to be at high ...

Gaming is rapidly evolving from a branding channel into a measurable growth engine for advertisers—and a new campaign from ...

A novel, accurate, easy-to-use biomarker test might help flag excessive alcohol use in steatotic liver disease (SLD), ...

A beginner-friendly guide to learning crypto technical analysis, covering chart patterns, indicators, tools, and practical ...

A new study suggests that AI can analyze routine coronary artery calcium (CAC) scans to measure pericardial fat and ...

From the pit garage to the grandstands packed with fans, there’s a whole lot more behind modern racing than just loud engines ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon make it possible to more precisely match patients with their optimal therapy.

Delinea to Host Its Inaugural Delinea Edge Customer Conference in 2027 (GlobeNewswire News Room) Delinea today announced ...

This issue of Transforming Care looks at how employees of health care systems are working to make AI useful while also ...

A European study reveals cardiovascular risk patterns in type 1 diabetes, highlighting the need for tailored prevention strategies to catch complications early.

Innovative diagnostics may reduce ~9-year diagnosis delay, but systemic barriers to implementation remain.